Medical News

Surgery

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lipskar AM et al. - Low-dose rapamycin inhibits tumor growth and angiogenesis in human ES without inhibiting the phosphorylation of p70s6k and Akt. Cyclooxygenase 2 levels are inhibited by low-dose treatment of ES with rapamycin. Cyclooxygenase 2 suppression may mediate the antiangiogenic effect of rapamycin in Ewing sarcoma.

Related Articles

Coincident expression of beta-catenin and cyclin D1 in endometrial stromal tumors and related high-grade sarcomas
Modern Pathology, 11/11/09    Relevance Score: 92%

Histiocytic sarcoma with interdigitating dendritic cell differentiation: A case report with fine needle aspiration cytology and review of literature
Diagnostic Cytopathology, 10/28/09    Relevance Score: 90%

Skeletal metastasis from sarcoma: a report of three cases
European Journal of Orthopaedic Surgery & Traumatology, 10/23/09    Relevance Score: 89%

Alveolar soft-part sarcoma of the tongue in a 17-month-old
ENT Journal, 10/19/09    Relevance Score: 89%

Radiological assessment following thermoradiation therapy for primary pleural synovial sarcoma: case report
Medical Oncology, 10/19/09    Relevance Score: 89%

Today in Surgical Oncology...keeping you current

Pigmented Epithelioid Melanocytoma: Favorable Outcome After 5-year Follow-up
American Journal of Surgical Pathology , 12/08/09

The Utility of Metaiodobenzylguanidine Single Photon Emission Computed Tomography/Computed Tomography (MIBG SPECT/CT) for the Diagnosis of Pheochromocytoma
Annals of Surgical Oncology, 12/08/09

Controversies in Thyroid Pathology: Thyroid Capsule Invasion and Extrathyroidal Extension
Annals of Surgical Oncology, 12/08/09